XBiotech Inc. (XBIT)
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.
$228.47M
Mr. John Simard
93.00
Austin, TX
Apr 15, 2015
-6.47
$-1.16
32.22
47.08
-1,435.30%
-3.81
0.47
54.72
46.87
-12.09%
-11.95%
Similar stocks (20)
Edgewise Therapeutics, Inc.
EWTX
Phathom Pharmaceuticals, Inc.
PHAT
Day One Biopharmaceuticals, Inc.
DAWN
Erasca, Inc.
ERAS
Stoke Therapeutics, Inc.
STOK
Replimune Group, Inc.
REPL
Absci Corporation
ABSI
C4 Therapeutics, Inc.
CCCC
Inozyme Pharma, Inc.
INZY
2seventy bio, Inc.
TSVT
Generation Bio Co.
GBIO
Acumen Pharmaceuticals, Inc.
ABOS
Adverum Biotechnologies, Inc.
ADVM
X4 Pharmaceuticals, Inc.
XFOR
Eledon Pharmaceuticals, Inc.
ELDN
Kronos Bio, Inc.
KRON
Passage Bio, Inc.
PASG
Kezar Life Sciences, Inc.
KZR
Oncternal Therapeutics, Inc.
ONCT
Galera Therapeutics, Inc.
GRTX
ETF Exposure (20)
ETFMG Treatments, Testing and Advancements ETF
GERM
0.48%
iShares Micro-Cap ETF
IWC
0.03088%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
Vanguard Russell 2000 Value Index Fund
VTWV
0.01%
iShares Russell 2000 Value ETF
IWN
0.00965%
iShares Russell 2000 ETF
IWM
0.00372%
ProShares Ultra Russell2000
UWM
0.0017163135146785358%
ProShares UltraPro Russell2000
URTY
8.460377919350814e-4%
ProShares Hedge Replication ETF
HDG
7.192128640297061e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (20)
Edgewise Therapeutics, Inc.
EWTX
Phathom Pharmaceuticals, Inc.
PHAT
Day One Biopharmaceuticals, Inc.
DAWN
Erasca, Inc.
ERAS
Stoke Therapeutics, Inc.
STOK
Replimune Group, Inc.
REPL
Absci Corporation
ABSI
C4 Therapeutics, Inc.
CCCC
Inozyme Pharma, Inc.
INZY
2seventy bio, Inc.
TSVT
Generation Bio Co.
GBIO
Acumen Pharmaceuticals, Inc.
ABOS
Adverum Biotechnologies, Inc.
ADVM
X4 Pharmaceuticals, Inc.
XFOR
Eledon Pharmaceuticals, Inc.
ELDN
Kronos Bio, Inc.
KRON
Passage Bio, Inc.
PASG
Kezar Life Sciences, Inc.
KZR
Oncternal Therapeutics, Inc.
ONCT
Galera Therapeutics, Inc.
GRTX
ETF Exposure (20)
ETFMG Treatments, Testing and Advancements ETF
GERM
0.48%
iShares Micro-Cap ETF
IWC
0.03088%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
Vanguard Russell 2000 Value Index Fund
VTWV
0.01%
iShares Russell 2000 Value ETF
IWN
0.00965%
iShares Russell 2000 ETF
IWM
0.00372%
ProShares Ultra Russell2000
UWM
0.0017163135146785358%
ProShares UltraPro Russell2000
URTY
8.460377919350814e-4%
ProShares Hedge Replication ETF
HDG
7.192128640297061e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%